Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes-Reference-Cited by-同舟云学术

Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes

Published:2014-10 Issue:4 Volume:26 Page:549-564
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Wolf Monika Julia,Adili Arlind,Piotrowitz Kira,Abdullah Zeinab,Boege Yannick,Stemmer Kerstin,Ringelhan Marc,Simonavicius Nicole,Egger Michèle,Wohlleber Dirk,Lorentzen Anna,Einer Claudia,Schulz Sabine,Clavel Thomas,Protzer Ulrike,Thiele Christoph,Zischka Hans,Moch Holger,Tschöp Matthias,Tumanov Alexei V.,Haller Dirk,Unger Kristian,Karin Michael,Kopf Manfred,Knolle Percy,Weber Achim,Heikenwalder Mathias

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference44 articles.

1. Cancer Facts & Figures,2007

2. The genetics of NAFLD;Anstee;Nat. Rev. Gastroenterol. Hepatol.,2013

3. Role of immunodeficient animal models in the development of fructose induced NAFLD;Bhattacharjee;J. Nutr. Biochem.,2014

4. Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH;Caballero;J. Hepatol.,2009

5. Histological and immunohistochemical assessment of liver biopsies in morbidly obese patients;Caballero;Histol. Histopathol.,2012

Cited by 561 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with 1.25% cholesterol enriched diet produces severe fatty liver disease characterized by advanced fibrosis and inflammation and impaired autophagy in mice;The Journal of Nutritional Biochemistry;2024-12

2. NAFLD-associated hepatocellular carcinoma (HCC) – A compelling case for repositioning of existing mTORc1 inhibitors;Pharmacological Research;2024-10

3. The immune microenvironment of steatotic hepatocellular carcinoma: Current findings and future prospects;Hepatology Communications;2024-09

4. SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8+ T cell activation;Cell Metabolism;2024-09

5. Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma;Clinical Gastroenterology and Hepatology;2024-09